Skip to main content

Bernstein Jeffrey Daniel's Form 4 filing

Privia Health Group, Inc. (PRVA) · filed May 10, 2023

Accession no.
0001209191-23-028495
Filed
May 10, 2023
Trade date
May 8, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market sales total $536.6M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bernstein Jeffrey DanielCIK 0001859499Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 8, 2023Common StockSSaleDisposed−24,819,473$21.62F1−$536,597,006.26110,337Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), Broad Street Principal Investments, L.L.C., MBD 2013 Holdings L.P. and Bridge Street 2013 Holdings L.P. offered and sold an aggregate 24,819,473 shares of Common Stock as set forth in the final prospectus filed by the Issuer on May 5, 2023, which offering was consummated on May 8, 2023 (the "Offering"). The amount above represents the $22.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.385 per share of Common Stock.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)